Expression of ErbB2 enhances radiation-induced NF-κB activation

Oncogene

Volumn 23, Issue 2, 2004, Pages 535-545

  Guo, Guozheng ^a,c   Wang, Tieli ^a   Gao, Qian ^b   Tamae, Daniel ^a   Wong, Patty ^a   Chen, Tammy ^a   Chen, Wei Chung ^a   Shively, John E ^a   Wong, Jeffery Y C ^a   Li, Jian Jian ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b BIO RAD LABORATORIES   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; ErbB2; NF B; Radioresistance

Indexed keywords

CYCLIN B1; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL; PROTEIN BCL 2; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ACTIVATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE OVEREXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFRARED RADIATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN INDUCTION; STEADY STATE; UPREGULATION;

ANTIBODIES, MONOCLONAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN B; CYCLIN D1; ENZYME ACTIVATION; HUMANS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION, IONIZING; RECEPTOR, ERBB-2;

MINK CELL FOCUS-FORMING VIRUS;

EID: 10744229156     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207149     Document Type: Article

References (69)

1. Baeuerle PA and Baltimore D. (1996). Cell, 87, 13-20.
2. Baldwin Jr AS. (1996). Annu. Rev. Immunol., 14, 649-683.
3. Barkett M and Gilmore TD. (1999). Oncogene, 18, 6910-6924.
4. Barnes EA, Kong M, Ollendorff V and Donoghue DJ. (2001). EMBO J., 20, 2214-2223.
5. Beetz A, Peter RU, Oppel T, Kaffenberger W, Rupec RA, Meyer M, van Beuningen D, Kind P and Messer G. (2000). Int. J. Radiat. Biol., 76, 1443-1453.
6. Bernard D, Monte D, Vandenbunder B and Abbadie C. (2002). Oncogene, 21, 4392-4402.
7. Bowers G, Reardon D, Hewitt T, Dent P, Mikkelsen RB, Valerie K, Lammering G, Amir C and Schmidt-Ullrich RK. (2001). Oncogene, 20, 1388-1397.
8. Brach MA, Mass R, Sherman ML, Gunji H, Weichselbaum R and Kufe D. (1991). J. Clin. Invest., 88, 691-695.
9. Bradbury CM, Markovina S, Wei SJ, Rene LM, Zoberi I, Horikoshi N and Gius D. (2001). Cancer Res., 61, 7689-7696.
10. Chen X, Shen B, Xia L, Khaletzkiy A, Chu D, Wong JY and Li JJ. (2002). Cancer Res., 62, 1213-1221.
11. Cogswell PC, Guttridge DC, Funkhouser WK and Baldwin Jr AS. (2000). Oncogene, 19, 1123-1231.
12. Contessa JN, Hampton J, Lammering G, Mikkelsen RB, Dent P, Valerie K and Schmidt-Ullrich RK. (2002). Oncogene, 21, 4032-4041.
13. Daosukho C, Kiningham K, Kasarskis EJ, Ittarat W and St Clair DK. (2002). Oncogene, 21, 3603-3610.
14. Delhalle S, Deregowski V, Benoit V, Merville MP and Bours V. (2002). Oncogene, 21, 3917-3924.
15. Fornace Jr AJ, Amundson SA, Bittner M, Myers TG, Meltzer P, Weinsten JN and Trent J. (1999). Gene Expression, 7, 387-400.
16. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG and Hauser CA. (1996). J. Biol. Chem., 271, 7992-7998.
17. Gius D, Botero A, Shah S and Curry HA. (1999). Toxicol. Lett., 106, 93-106.
18. Granville DJ, Carthy CM, Jiang H, Levy JG, McManus BM, Matroule JY, Piette J and Hunt DW. (2000). Blood, 95, 256-262.
19. Grdina DJ, Murley JS, Kataoka Y and Calvin DP. (2002). Semin. Radiat. Oncol., 12, 103-111.
20. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, Khaletskiy A, Li Z, Weydert C, Longmate JA, Huang TT, Spitz DR, Oberley LW and Li JJ. (2003). Mol. Cell. Biol., 23, 2362-2378.
21. Gupta AK, Bakanauskas VJ, Cerniglia GJ, Cheng Y, Bernhard EJ, Muschel RJ and McKenna WG. (2001). Cancer Res., 61, 4278-4482.
22. Hallahan DE, Virudachalam S and Kuchibhotla J. (1998). Cancer Res., 58, 5484-5488.
23. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, Hong WK and Mao L. (2002). Cancer Res., 62, 6414-6417.
24. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK and Mao L. (2001). Clin. Cancer Res., 7, 2458-2462.
25. Hayman MJ and Enrietto PJ. (1991). Cancer Cells, 3, 302-307.
26. Hermanto U, Zong CS and Wang LH. (2001). Oncogene, 20, 7551-7562.
27. Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A and Mitchell JB. (1999). Oncology, 13, 11-22.
28. Kato T, Duffey DC, Ondrey FG, Dong G, Chen Z, Cook JA, Mitchell JB and Van Waes C. (2000). Head Neck, 22, 748-759.
29. Kurland JF and Meyn RE. (2001). Int. J. Cancer, 96, 327-333.
30. Kurokawa H and Arteaga CL. (2001). Clin. Cancer Res., 7, 4436s-4442s, discussion 4411s-4412s.
31. Labudda K, Meyer S and Hayman MJ. (1995). Virology, 206, 269-275.
32. Lammering G, Lin PS, Contessa JN, Hampton JL, Valerie K and Schmidt-Ullrich RK. (2001a). Int. J. Radiat. Oncol. Biol. Phys., 51, 775-784.
33. Lammering G, Valerie K, Lin PS, Mikkelsen RB, Contessa JN, Feden JP, Farnsworth J, Dent P and Schmidt-Ullrich RK. (2001b). Clin. Cancer Res., 7, 682-690.
34. Lee S, Yang W, Lan KH, Sellappan S, Klos K, Hortobagyi G, Hung MC and Yu D. (2002). Cancer Res., 62, 5703-5710.
35. Lee SJ, Dimtchev A, Lavin MF, Dritschilo A and Jung M. (1998). Oncogene, 17, 1821-1826.
36. Li JJ, Rhim JS, Schlegel R, Vousden KH and Colburn NH. (1998). Oncogene, 16, 2711-2721.
37. Li N and Karin M. (1998). Proc. Natl. Acad. Sci. USA, 95, 13012-13017.
38. Li Z, Xia L, Lee ML, Khaletskiy A, Wang J, Wong JYC and Li JJ. (2001). Radiat. Res., 155, 543-553.
39. Liang K, Jin W, Knuefermann C, Schmidt M, Mills GB, Ang KK, Milas L and Fan Z. (2003). Mol. Cancer Ther., 2, 353-360.
40. Locke JE, Bradbury CM, Wei SJ, Shah S, Rene LM, Clemens RA, Roti Roti J, Horikoshi N and Gius D. (2002). Int. J. Radiat. Biol., 78, 493-502.
41. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin Jr AS and Mayo MW. (2000). Mol. Cell. Biol., 20, 1626-1638.
42. McBride WH, Pajonk F, Chiang CS and Sun JR. (2002). Mil. Med., 167, 66-67.
43. Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S and Saya H. (1998). Oncogene, 16, 933-943.
44. Miyakoshi J and Yagi K. (2000). Br. J. Cancer, 82, 28-33.
45. Pegram M and Slamon D. (2000). Semin. Oncol., 27, 13-19.
46. Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM, Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy JA and Slamon DJ. (1998), J. Clin. Oncol., 16, 2659-2671.
47. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ and Sonenshein GE. (2001). Oncogene, 20, 1287-1299.
48. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB and Slamon DJ. (1994). Oncogene, 9, 1829-1838.
49. Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ and Slamon DJ. (1999). Cancer Res., 59, 1347-1355.
50. Ravi R and Bedi A. (2002). Cancer Res., 62, 1583-1587.
51. Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C, Fuchs EJ and Bedi A. (2001). Nat. Cell Biol., 3, 409-416.
52. Raziuddin A, Court D, Sarkar FH, Liu YL, Kung H and Raziuddin R. (1997). J. Biol. Chem., 272, 15715-15720.
53. Rice NR and Ernst MK. (1993). EMBO J., 12, 4685-4695.
54. Schmidt M, McWatters A, White RA, Groner B, Wels W, Fan Z and Bast Jr RC. (2001). Gynecol. Oncol., 80, 145-155.
55. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK and Chen PB. (1997). Oncogene, 15, 1191-1197.
56. Schmidt-Ullrich RK, Valerie K, Fogleman PB and Walters J. (1996). Radiat. Res., 145, 81-85.
57. Sen R and Baltimore D. (1986). Cell, 47, 921-928.
58. Shao R, Karunagaran D, Zhou BP, Li K, Lo SS, Deng J, Chiao P and Hung MC. (1997). J. Biol. Chem., 272, 32739-32742.
59. Sherman L, Sleeman JP, Hennigan RF, Herrlich P and Ratner N. (1999). Oncogene, 18, 6692-6699.
60. Slamon DJ. (1990). Cancer Invest., 8, 253.
61. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
62. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK and Mao L. (2000). Cancer Res., 60, 4000-4004.
63. Stoica GE, Franke TF, Wellstein A, Morgan E, Czubayko F, List HJ, Reiter R, Martin MB and Stoica A. (2003). Oncogene, 22, 2073-2087.
64. Tan M, Jing T, Lan KH, Neal CL, Li P, Lee S, Fang D, Nagata Y, Liu J, Arlinghaus R, Hung MC and Yu D. (2002). Mol. Cell, 9, 993-1004.
65. Taylor WR and Stark GR. (2001). Oncogene, 20, 1803-1815.
66. Yang HY, Zhou BP, Hung MC and Lee MH. (2000). J. Biol. Chem., 275, 24735-24739.
67. Yang JP, Hori M, Takahashi N, Kawabe T, Kato H and Okamoto T. (1999). Oncogene, 18, 5177-5186.
68. Zhang Z, Huang C, Li J, Leonard SS, Lanciotti R, Butterworth L and Shi X. (2001). Arch. Biochem. Biophys., 392, 311-320.
69. Zhou D, Yu T, Chen G, Brown SA, Yu Z, Mattson MP and Thompson JS. (2001). Int. J. Radiat. Biol., 77, 763-772.